Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs

Status unconfirmed · Phase 2/Phase 3

Conditions studied: Keratoconus, Ectasia

In brief

This study will determine the efficacy of collagen cross linking for progressive keratoconus and ectasia after lasik. It will try and determine which is a more effective treatment: collagen cross linking alone or collagen cross linking combined with Intacs, a treatment which has already been proven to be effective in decreasing corneal curvature in patients with keratoconus.

Key facts

Study ID

NCT01081561

Run by

Yaron S. Rabinowitz M.D.

People needed

600

Starts

2009-01-21

Expected to finish

2021-06-30

Last updated by the study team

2018-10-02

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• progressive keratoconus or ectasia

You may not qualify if…

• cornea thinner than 400um
• K readings greater than 60D
• Central corneal scarring

Where it is running

• Cornea Eye Institute, 50 North La Cienaga Blvd, #340 — Beverly Hills, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.